The conference, """"""""Finding a Research Path for the Identification of Biomarkers of Sleepiness"""""""" will be a 1.5 meeting of world-renown experts in sleep deprivation research, proteomics, genomics and related fields who are being convened to discuss what is known concerning potential biomarkers of sleepiness and to develop a research pathway towards identifying clinically and research usable biomarkers of sleepiness. To these ends, the objectives of this conference are the following: 1. Provide an overview of the utility of current instruments to detect and quantify levels of sleepiness including both subjective and objective tools or techniques;2. Present current research on the use of genomic, proteomic and molecular approaches to assess sleepiness with the emphasis on how such techniques might be used clinically or for clinical research;3. Stimulate research into the development of clinically useful biomarkers of sleepiness by formulating a research pathway for investigators to follow. The conference will be sponsored by the Harvard Medical School, Division of Sleep Medicine and held on September 21-22, 2010 in Boston, MA. During these 1.5 days, international and national scholars will give presentations and participate in panel discussions focused in 3 areas: 1) Current Instruments to Assess Sleepiness;2) Genomic, Proteomic and Molecular Markers of Sleepiness;and 3) Developing a Biomarker of Sleepiness. We expect to have an audience of approximately 100 participants consisting of a cross-disciplinary mixture of senior and more junior investigators, sleep researchers and investigators from other fields, and interested parties from industry. The proceedings will be published in a journal indexed in PubMed and a link to the proceedings will be posted on the Division of Sleep Medicine website.
The conference on """"""""Finding a Research Path for the Identification of Biomarkers of Sleepiness"""""""" will be held on September 21-22, 2009 in Boston, MA. The overall objective of this conference is to develop research pathways for investigators to follow so that a clinically and research useful biomarker to quantify and detect sleepiness can be developed. Such a biomarker will have important utility in reducing the public health and economic consequences of sleepiness.
| Mullington, Janet M; Czeisler, Charles A; Goel, Namni et al. (2011) Panel discussion: current status of measuring sleepiness. J Clin Sleep Med 7:S22-5 |
| Thimgan, Matthew S; Duntley, Stephen P; Shaw, Paul J (2011) Changes in gene expression with sleep. J Clin Sleep Med 7:S26-7 |
| Quan, Stuart F (2011) Finding a research path for the identification of biomarkers of sleepiness. J Clin Sleep Med 7:S4-5 |
| Davis, Christopher J; Clinton, James M; Jewett, Kathryn A et al. (2011) Delta wave power: an independent sleep phenotype or epiphenomenon? J Clin Sleep Med 7:S16-8 |
| Albert, Michelle A (2011) Biomarkers and heart disease. J Clin Sleep Med 7:S9-11 |
| Naidoo, Nirinjini (2011) Potential of proteomics as a bioanalytic technique for quantifying sleepiness. J Clin Sleep Med 7:S28-30 |
| Balkin, Thomas J (2011) Behavioral biomarkers of sleepiness. J Clin Sleep Med 7:S12-5 |
| Carpagnano, Giovanna E (2011) Exhaled breath analysis and sleep. J Clin Sleep Med 7:S34-7 |
| Czeisler, Charles A (2011) Impact of sleepiness and sleep deficiency on public health--utility of biomarkers. J Clin Sleep Med 7:S6-8 |
| Church, George M (2011) New technologies for integrating genomic, environmental and trait data. J Clin Sleep Med 7:S43-4 |
Showing the most recent 10 out of 14 publications
